23andMe

📍 Sunnyvale, United States👥 696 employees💰 Last funded Dec 2020
23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers the 23andMe Therapeutics group, currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. 23andMe was named as one of the San Francisco Chronicles Top Workplaces and one of Comparablys Best Places to Work in 2022. CEO, Anne Wojcicki was also named one of Glassdoor’s top CEOs in 2019 and one of Comparably’s "Best CEOs for Women" in 2021 and 2022. More information is available at www.23andMe.com.
14
Total investors
1
Early stage
1
Mid stage
0
Late stage
Founded
Investor geography5 countries
United States
10
France
1
Canada
1
Singapore
1
Brazil
1
Investor activity2007–2020 · investors recorded per year
200712010120172201852019320202
Recent (last 2y)Earlier
Frequently asked questions
Who invested in 23andMe?
23andMe has 14 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did 23andMe last raise funding?
The most recent investment in 23andMe recorded on gritt.io was in December 2020.
What industry is 23andMe in?
23andMe operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is 23andMe based?
23andMe is headquartered in Sunnyvale, United States.